A previous study demonstrated that 3,6-bromoindirubin 3′-oxime (BIO), a GSK3β inhibitor, prevents lethal GvHD in a humanized xenograft in mice without affecting donor T-cell engraftment [233]. This evidence concerns the gene GSK3B and graft versus host disease.